Daniel Brownell
Director, Research & Development at AOBiome Therapeutics
Daniel Brownell currently serve as the Director of R&D at AOBiome, responsible for preclinical research, study execution, and clinical support. Previously, he have served as the Director of R&D and Manufacturing at Sample6, who developed a line of rapid diagnostics for the food safety industry.
Title: Ammonia Oxidizing Bacteria as a Treatment for Inflammatory Skin Disease
- Background information of AOBiome
- Mechanisms of Action of Ammonia Oxidizing Bacteria
- Clinical Trials using Ammonia Oxidizing Bacteria